Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023
Thu, March 30, 2023
Wed, March 29, 2023

David Nierengarten Reiterated (STRO) at Buy and Held Target at $20 on, Mar 31st, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-mar-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
David Nierengarten of Wedbush, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $20 on, Mar 31st, 2023.

David has made no other calls on STRO in the last 4 months.



There are 2 other peers that have a rating on STRO. Out of the 2 peers that are also analyzing STRO, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Increased Target to $25 on, Friday, January 13th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $18 on, Tuesday, January 10th, 2023